The emerging therapy of the medication represents a significant advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment